Incyte Corp. (INCY)

Index:

Nasdaq 100

$ 87.57
   
  • Change Today:
    $0.26
  • 52 Week High: $88.54
  • 52 Week Low: $55.11
  • Currency: US Dollars
  • Shares Issued: 193.43m
  • Volume: 2,070,856
  • Market Cap: $16,939m
  • RiskGrade: 196

Latest ShareCast News

FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir

By Alexander Bueso

Date: Friday 20 Nov 2020

(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Incyte Corp. Market Data

Currency US Dollars
Share Price $ 87.57
Change Today $ 0.26
% Change 0.30 %
52 Week High $88.54
52 Week Low $55.11
Volume 2,070,856
Shares Issued 193.43m
Market Cap $16,939m
RiskGrade 196

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 12
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Oct-2025

Time Volume / Share Price
16:00 487,812 @ $87.57
15:59 260 @ $87.56
15:59 230 @ $87.56
15:59 100 @ $87.55
15:59 100 @ $87.55

Top of Page